Argenx Se (ARGX) Other Accumulated Expenses (2015 - 2018)
Argenx Se's (ARGX) quarterly Other Accumulated Expenses came in at $29676.3 in Q4 2018, up 180.05% on a YoY basis from $10596.9 in Q4 2017, and up 180.05% quarter-over-quarter from $10596.9 in Q4 2017.
Analysis
Argenx Se (ARGX) Other Accumulated Expenses (2015 - 2018) Analysis & Trends
Argenx Se (ARGX) has reported Other Accumulated Expenses for 4 consecutive years, with $29676.3 the latest figure, recorded in Q4 2018.
- For the quarter ending Q4 2018, Other Accumulated Expenses rose 180.05% year-over-year to $29676.3; the trailing twelve-month figure through Dec 2018 stood at $29676.3 (up 180.05% YoY), and the FY2018 full-year result was $29676.3, up 191.98% from the prior year.
- Other Accumulated Expenses advanced to $29676.3 in Q4 2018 per ARGX's latest filing, from $10596.9 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $29676.3 in Q4 2018 and bottomed at $5480.6 in Q4 2015.
- Historically, Other Accumulated Expenses has averaged $17376.9 across 4 years, with a median of $17175.4 in 2016.
- The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses surged 333.42% in 2016, then plunged 55.39% in 2017.
- Over 4 years, Other Accumulated Expenses stood at $5480.6 in 2015, then surged by 333.42% to $23753.9 in 2016, then slumped by 55.39% to $10596.9 in 2017, then jumped by 180.05% to $29676.3 in 2018.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $29676.3, $10596.9, and $23753.9 for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 29,676.31 |
| Dec 31, 2017 | 10,596.89 |
| Dec 31, 2016 | 23,753.93 |
| Dec 31, 2015 | 5,480.59 |